- Nukkleus Inc. **regained full compliance** with the Nasdaq Global Market’s minimum market capitalization requirement on **September 26, 2025**.  **[1787518_0001213900-25-092677_ea025912001ex99-1_nukkleus.htm:0]** **[1787518_0001213900-25-092677_ea0259120-8k_nukkleus.htm:1]** 
- The company was previously notified of non-compliance on August 28, 2025, and had until February 24, 2026, to meet the **$50,000,000 minimum market value** requirement.  **[1787518_0001213900-25-092677_ea0259120-8k_nukkleus.htm:1]** 
- This compliance was achieved ahead of schedule, supported by a **$10 million private placement** and a planned **$250 million line of equity**.  **[1787518_0001213900-25-092677_ea025912001ex99-1_nukkleus.htm:0]** **[1787518_0001213900-25-092677_ea0259120-8k_nukkleus.htm:1]** 
- The company's addition to the **Russell Microcap Index** and regaining Nasdaq compliance are expected to enhance investor visibility, credibility, and facilitate its strategic acquisition program in the Aerospace and Defense (A&D) sector.  **[1787518_0001213900-25-092677_ea025912001ex99-1_nukkleus.htm:0]**

Nukkleus Inc. Regains Nasdaq Compliance

- Nukkleus Inc. has secured a strategic **$250 million Equity Line** with Esousa Holding Group LLC, an existing shareholder and institutional investor.  **[1787518_0001213900-25-089259_ea025798201ex99-1_nukkleus.htm:0]** 
- This facility is intended to fund the company's strategic growth initiatives, particularly its robust **mergers and acquisitions (M&A) pipeline**, and support the expansion of its next-generation multi-domain defense solutions portfolio.  **[1787518_0001213900-25-089259_ea025798201ex99-1_nukkleus.htm:0]** 
- Under the agreement, Nukkleus has the right, but not the obligation, to sell up to **$250 million** in common stock over a **36-month period**, with drawdowns generally limited to **20% of the Company's trading volume**.  **[1787518_0001213900-25-089259_ea025798201ex99-1_nukkleus.htm:0]** 
- Access to these funds is contingent upon a registration statement covering the resale of the underlying shares being filed with and declared effective by the Securities and Exchange Commission.  **[1787518_0001213900-25-089259_ea025798201ex99-1_nukkleus.htm:0]**

Nukkleus Inc. Secures $250 Million Growth Facility

- Nukkleus Inc. announced the signing of an Amended and Restated Securities Purchase Agreement on **September 15, 2025**, to **acquire 100%** of Star 26 Capital Inc., a defense acquisition company.  **[1787518_0001213900-25-087962_ea025738701ex99-1_nukkleus.htm:0]** **[1787518_0001213900-25-087962_ea025738701ex10-1_nukkleus.htm:0]** **[1787518_0001213900-25-087962_ea0257387-8k_nukkleus.htm:1]** 
- The consideration for the acquisition includes **$24,000,000** in cash and promissory notes, **4,770,340 shares** of Nukkleus common stock, and five-year warrants to purchase **12,017,648 shares** of common stock at an exercise price of **$1.50 per share**.  **[1787518_0001213900-25-087962_ea025738701ex10-1_nukkleus.htm:0]** **[1787518_0001213900-25-087962_ea0257387-8k_nukkleus.htm:1]** **[1787518_0001213900-25-087962_ea025738701ex10-1_nukkleus.htm:10]** 
- Star 26's portfolio includes 100% of Rimon (a supplier for the Iron Dome), 67% of Water.io (smart hydration technology), and a convertible loan to ITS/Positech (advanced motion control and targeting technologies).  **[1787518_0001213900-25-087962_ea025738701ex99-1_nukkleus.htm:0]** **[1787518_0001213900-25-087962_ea0257387-8k_nukkleus.htm:1]** 
- The closing of the acquisition is subject to customary conditions, including **shareholder approval** by Nukkleus Inc., as Menachem Shalom, CEO of Nukkleus, is also a controlling shareholder and CEO of Star 26.  **[1787518_0001213900-25-087962_ea025738701ex99-1_nukkleus.htm:0]** **[1787518_0001213900-25-087962_ea025738701ex99-1_nukkleus.htm:1]** **[1787518_0001213900-25-087962_ea0257387-8k_nukkleus.htm:1]** **[1787518_0001213900-25-087962_ea025738701ex10-1_nukkleus.htm:1]** **[1787518_0001213900-25-087962_ea025738701ex10-1_nukkleus.htm:10]**

Nukkleus Inc. to Acquire 100% of Star 26 Capital Inc.

- Nukkleus Inc. entered into a Stock Purchase Agreement on **September 1, 2025**, to acquire **100%** of **Tiltan Software Engineering Ltd.**, an Israeli company specializing in **AI software solutions for the defense and aerospace industry**.  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]** 
- The acquisition is for a total purchase price paid through a combination of cash and equity, as detailed below  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]** **[1787518_0001213900-25-082948_ea025549501ex10-1_nukkleus.htm:7]** :

| Metric | Q3 2025 |
|---|---|
| Total Purchase Price (NIS Millions) | **47.6**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]** **[1787518_0001213900-25-082948_ea025549501ex10-1_nukkleus.htm:7]**  |
| Total Purchase Price (USD Millions) | **14.0**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]**  |
| Cash Component (NIS Millions) | **35.7**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]**  |
| Cash Component (USD Millions) | **10.5**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]**  |
| Equity Component (NIS Millions) | **11.9**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]**  |
| Equity Component (USD Millions) | **3.5**  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:1]**  |

- Nukkleus will establish **Nukkleus Defense AI Applications, Inc.**, a new Delaware subsidiary, to commercialize Tiltan's defense-related software solutions, marking a strategic expansion into defense and aerospace markets.  **[1787518_0001213900-25-082948_ea0255495-8k_nukkleus.htm:2]**

Nukkleus Inc. Acquires Tiltan Software Engineering Ltd.

- Nukkleus Inc. has established **Nukkleus Defense Technologies Inc.**, a wholly owned subsidiary, to serve as the cornerstone of its defense-focused activities, initially through the commercialization of advanced third-party solutions and, over time, through the development of proprietary technologies.  **[1787518_ef78e761f78e45bd99b2e11f72b29b27_0]** 
- The company has entered into an **exclusive three-year U.S. distribution agreement** with **BladeRanger Ltd.** for its advanced drone payload systems, with an option to extend for an additional five years, subject to performance.  **[1787518_ef78e761f78e45bd99b2e11f72b29b27_0]** 
- Under the terms of the agreement, Nukkleus will provide an **upfront licensing payment** and has committed to **minimum annual purchase volumes** that will increase progressively over the three-year term.  **[1787518_ef78e761f78e45bd99b2e11f72b29b27_1]** 
- This strategic pivot aims to capitalize on the global drone payload market, which was valued at approximately **$7.2 billion in 2020** and is expected to reach **$33.3 billion by 2030**.  **[1787518_ef78e761f78e45bd99b2e11f72b29b27_0]**

Nukkleus Establishes Defense Subsidiary and Secures Exclusive U.S. Distribution Agreement

- Nukkleus Inc. entered into an **Exclusive Distribution Agreement** with Blade Ranger Ltd. on **August 20, 2025**, granting Nukkleus exclusive U.S. distribution rights for Blade Ranger's proprietary drone payload in the **defense and homeland security sector**.  **[1787518_0001213900-25-080347_ea025444501ex10-1_nukkleus.htm:0]** **[1787518_0001213900-25-080347_ea0254445-8k_nukkleus.htm:1]** 
- Under the agreement, Nukkleus will pay Blade Ranger **$100,000** for the exclusive rights, to be made in **four quarterly payments**, with the first payment due by the end of November 2025.  **[1787518_0001213900-25-080347_ea0254445-8k_nukkleus.htm:1]** **[1787518_0001213900-25-080347_ea025444501ex10-1_nukkleus.htm:2]** 
- Nukkleus committed to minimum purchases of **5 units in Year 1, 10 units in Year 2, and 15 units in Year 3**; meeting these targets extends the agreement for five additional years with a **20 unit annual commitment**.  **[1787518_0001213900-25-080347_ea0254445-8k_nukkleus.htm:1]** **[1787518_0001213900-25-080347_ea025444501ex10-1_nukkleus.htm:2]** 
- As part of this strategic shift, Nukkleus will incorporate a new subsidiary, **Nukkleus Defense Technologies, Inc.**, to commercialize third-party defense-related products and explore proprietary solutions for the defense and aerospace markets.  **[1787518_0001213900-25-080347_ea0254445-8k_nukkleus.htm:1]**

Nukkleus (NUKK)